Key terms

About ACHV

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ACHV news

Apr 16 4:25pm ET Achieve Life Sciences: A Strong Buy for Tobacco Cessation Market Penetration Apr 16 4:15pm ET Achieve Life Sciences initiated with a Buy at JonesResearch Apr 01 9:00am ET Analysts Offer Insights on Healthcare Companies: Forian (FORA), Achieve Life Sciences (ACHV) and P3 Health Partners (PIII) Apr 01 6:50am ET Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Phathom Pharmaceuticals (PHAT) Mar 28 4:08pm ET Achieve Life Sciences reports Q4 EPS (26c), consensus (31c) Mar 28 8:05am ET Options Volatility and Implied Earnings Moves Today, March 28, 2024 Mar 25 8:00am ET Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024 Mar 20 8:07am ET Achieve Life Sciences announces data from cytisinicline ORCA program Mar 05 9:00am ET Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), ClearPoint Neuro (CLPT) Mar 05 8:41am ET Achieve Life Sciences price target lowered to $11 from $19 at Lake Street Feb 29 4:52pm ET Achieve Life Sciences Raises Funds for Clinical Trials Feb 29 2:15pm ET Buy Rating for Achieve Life Sciences on Cytisinicline’s Promising Future and Solid Financials Feb 29 8:29am ET Achieve Life reaches agreement with FDA on cytisinicline data requirements Feb 29 8:22am ET Achieve Life Sciences sells 13M shares at $4.585 in registered direct offering

No recent press releases are available for ACHV

ACHV Financials

1-year income & revenue

Key terms

ACHV Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ACHV Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms